Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study

Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Cardiology - Volume 174, Issue 2, 15 June 2014, Pages 400-403

E. Hertle, M.M.J. van Greevenbroek, I.C.W. Arts, C.J.H. van der Kallen, E.J.M. Feskens, C.G. Schalkwijk, C.D.A. Stehouwer,